동물용 감염증 진단 세계 시장 규모는 2024년에 15억 2,000만 달러로 예측 기간 중의 CAGR은 5.25%를 나타낼 전망이며, 2030년에는 20억 4,000만 달러에 달할 것으로 예측되고 있습니다.
세계 수의학 업계는 동물의 예방 건강 관리 및 진단에 중점을 둔 패러다임 전환을 경험하고 있습니다. 인수 공통 감염에 대한 우려와 가축에 대한 전염병 발생으로 인한 경제적 영향이 높아짐에 따라 첨단 동물 감염 진단에 대한 수요가 증가하고 있습니다. 동물 감염증 진단 세계 시장은 이 진화의 최전선에 있으며, 동물의 건강을 지키고, 음식의 안전을 확보하며, 동물과 인간 사이의 질병 전달을 방지하는 중요한 역할을 수행하고 있습니다.
| 시장 개요 | |
|---|---|
| 예측 기간 | 2026-2030 |
| 시장 규모 : 2024년 | 15억 2,000만 달러 |
| 시장 규모 : 2030년 | 20억 4,000만 달러 |
| CAGR : 2025-2030년 | 5.25% |
| 급성장 부문 | 분자진단 |
| 최대 시장 | 북미 |
인수 공통 감염 증가로 동물과 인간의 건강이 서로 관련되어 있다는 인식이 높아지고 있습니다. 조류 인플루엔자, 브루셀라증, 렙토스피라증 등의 질병은 동물과 인간 사이에서 감염될 수 있으며, 견고한 진단 도구의 필요성을 강조합니다. PCR(중합효소 연쇄반응)과 차세대 시퀀싱과 같은 진단기술의 발전은 동물 감염 진단의 정확성과 속도에 혁명을 가져왔습니다. 이러한 기술은 병원체의 조기 발견과 정확한 식별을 가능하게 합니다. 반려동물을 키우는 경향이 커짐에 따라 진단을 포함한 수의학 서비스에 대한 수요가 증가하고 있습니다. 반려동물 주인이 동물의 예방 건강 관리에 투자하는 경향이 강해지고 있으며 고급 진단 검사에 대한 수요가 높아지고 있습니다. 축산업의 세계화에 따라 국경을 넘어서는 질병 전달 위험이 높아지고 있습니다. 이 때문에 규제기관과 이해관계자는 동물과 소비자의 건강과 안전을 확보하기 위해 엄격한 진단 프로토콜을 실시하도록 요구되고 있습니다.
반려동물 사육 증가와 반려동물의 인간화
인수 공통 감염의 발생률 상승
진단 장비의 높은 비용
기술 진보
Global Veterinary Infectious Disease Diagnostics Market was valued at USD 1.52 Billion in 2024 and is expected to reach USD 2.04 Billion by 2030 with a CAGR of 5.25% during the forecast period.The global veterinary industry is experiencing a paradigm shift, with increased focus on preventive healthcare and diagnostics for animals. As concerns about zoonotic diseases and the economic impact of infectious outbreaks on livestock rise, the demand for advanced veterinary infectious disease diagnostics is growing. The Global Veterinary Infectious Disease Diagnostics Market is at the forefront of this evolution, playing a crucial role in safeguarding animal health, ensuring food safety, and preventing the transmission of diseases between animals and humans.
| Market Overview | |
|---|---|
| Forecast Period | 2026-2030 |
| Market Size 2024 | USD 1.52 Billion |
| Market Size 2030 | USD 2.04 Billion |
| CAGR 2025-2030 | 5.25% |
| Fastest Growing Segment | Molecular Diagnostics |
| Largest Market | North America |
The increasing incidence of zoonotic diseases has raised awareness about the interconnectedness of animal and human health. Diseases such as avian influenza, brucellosis, and leptospirosis can be transmitted between animals and humans, emphasizing the need for robust diagnostic tools. Advances in diagnostic technologies, such as PCR (Polymerase Chain Reaction) and next-generation sequencing, have revolutionized the accuracy and speed of veterinary infectious disease diagnostics. These technologies allow for early detection and precise identification of pathogens. The growing trend of pet ownership has led to an increased demand for veterinary services, including diagnostics. Pet owners are increasingly investing in preventive healthcare for their animals, driving the demand for sophisticated diagnostic tests. With the globalization of the livestock industry, the risk of disease transmission across borders has escalated. This has prompted regulatory bodies and stakeholders to implement stringent diagnostic protocols to ensure the health and safety of animals and consumers.
Key Market Drivers
Increasing Pet Ownership and Humanization of Pets
In recent years, there has been a notable global shift in the way people perceive and care for their pets. The increasing trend of pet ownership and the growing humanization of pets have not only led to an upsurge in spending on pet healthcare but have also been significant drivers of the veterinary infectious disease diagnostics market. This market, which plays a crucial role in ensuring the health and well-being of animals, has witnessed unprecedented growth as pet owners seek advanced diagnostic solutions for their beloved companions. According to the American Veterinary Medical Association (AVMA), the number of pet-owning households has significantly increased, with dog ownership growing at a faster pace rising from 31.3 million households in 1996 to 59.8 million in 2024. In comparison, cat-owning households have also seen growth, from 27 million to 42.1 million over the same period. This surge in pet ownership, coupled with the increasing humanization of pets, is driving the global veterinary infectious disease diagnostics market, as more pet owners seek advanced medical care for their animals. The worldwide surge in pet ownership is a multifaceted phenomenon, influenced by factors such as urbanization, changing lifestyles, and an increased understanding of the emotional and physical benefits that pets bring to their owners. As more people open their homes to pets, whether they be dogs, cats, birds, or exotic animals, the demand for comprehensive veterinary care has risen significantly.
This burgeoning population of pets has given rise to a corresponding demand for advanced diagnostic tools to detect and manage infectious diseases. Veterinary infectious disease diagnostics encompass a range of tests and procedures that aid in the identification and monitoring of diseases in animals. These diagnostics not only help in the early detection of illnesses but also play a crucial role in preventing the spread of infectious diseases among animals and, in some cases, to humans.
The increasing humanization of pets is another major trend shaping the veterinary infectious disease diagnostics market. Pet owners are now more inclined to view their animals as integral members of the family, leading to a greater willingness to invest in their health and well-being. This paradigm shift has translated into higher expectations for the quality of veterinary care, including advanced diagnostics, and has fueled the growth of the global market. Pet owners are seeking not just basic veterinary services but also cutting-edge diagnostics that can provide more accurate and timely results. This shift in consumer behaviour has prompted veterinary diagnostic companies to innovate and develop new technologies and testing methods to meet the evolving demands of pet owners.
Rising Incidence of Zoonotic Diseases
Zoonotic diseases, which are infections that can be transmitted between animals and humans, have garnered increased attention in recent years due to their potential for rapid spread and devastating impact on both animal and human populations. The rise in these diseases has led to a growing demand for effective diagnostic tools, driving the expansion of the global veterinary infectious disease diagnostics market. Zoonotic diseases represent a significant public health concern, as evidenced by outbreaks such as the H1N1 influenza pandemic and the more recent COVID-19 pandemic. These diseases can originate in animals and jump to humans through various means, including direct contact, consumption of contaminated food or water, and exposure to vectors like mosquitoes and ticks. According to the Centers for Disease Control and Prevention (CDC), zoonotic diseases are widespread both in the United States and globally. Research indicates that more than 60% of known infectious diseases in humans are transmitted from animals, and approximately 75% of new or emerging infectious diseases in humans originate from animals. This growing prevalence of zoonotic diseases is fueling the demand for advanced veterinary infectious disease diagnostics, driving market growth in this sector.
The interconnectedness of animal and human health is increasingly recognized as a crucial aspect of global health. As human populations expand and encroach on natural habitats, the risk of zoonotic disease transmission escalates. Climate change, international travel, and the global movement of goods further contribute to the complexity of disease transmission dynamics. Efficient and accurate diagnostics play a pivotal role in preventing, controlling, and managing zoonotic diseases. In response to the rising threat, the global veterinary infectious disease diagnostics market has witnessed substantial growth. Diagnostic techniques include traditional methods such as serological testing and microbial culture, as well as advanced molecular techniques like polymerase chain reaction (PCR) and next-generation sequencing.
Key Market Challenges
High Cost of Diagnostic Equipment
The field of veterinary diagnostics plays a crucial role in safeguarding the health of animals and preventing the spread of infectious diseases. As technology continues to advance, the demand for accurate and timely diagnostics in the veterinary sector has grown exponentially. However, one formidable challenge hindering the progress of the Global Veterinary Infectious Disease Diagnostics Market is the exorbitant cost associated with diagnostic equipment. The high cost of diagnostic equipment limits access to advanced veterinary diagnostics, especially in developing regions. Rural areas, where agriculture is a significant part of the economy, often lack access to state-of-the-art diagnostic tools. This limited accessibility can impede early detection and timely intervention, allowing infectious diseases to spread unchecked.
Veterinary clinics and laboratories, facing the burden of expensive diagnostic equipment, may struggle to invest in the latest technologies. The financial strain on these establishments not only affects their ability to provide cutting-edge services but also impacts their competitiveness in the market. High equipment costs can also hinder research and development efforts in veterinary diagnostics. Smaller companies and research institutions may find it challenging to invest in innovative technologies, slowing down progress in the field and limiting the development of new diagnostic methods. The cost of diagnostic services is inevitably passed on to pet owners and livestock farmers. This can deter individuals from seeking early diagnostic testing for their animals, leading to delayed disease detection and increased treatment costs in the long run.
Key Market Trends
Technological Advancements
In recent years, the global veterinary industry has experienced a significant transformation, with a sharp focus on technological advancements to address the challenges posed by infectious diseases in animals. The Veterinary Infectious Disease Diagnostics Market has witnessed a remarkable surge, driven by cutting-edge technologies that are revolutionizing the way diseases are diagnosed and treated in animals. One of the primary drivers of the veterinary infectious disease diagnostics market is the continuous evolution of diagnostic technologies. Traditional methods are being replaced or complemented by more sophisticated and rapid techniques. Molecular diagnostics, next-generation sequencing, and advanced imaging technologies have become instrumental in providing quick and accurate diagnoses. These technologies not only enhance the speed of diagnosis but also improve the precision and reliability of results.
Segmental Insights
Technology Insights
Based on technology, Molecular Diagnostics emerged as the fastest growing segment in the global market for Veterinary Infectious Disease Diagnostics during the forecast period. Molecular diagnostic methods, including techniques like Polymerase Chain Reaction (PCR), enable the detection of pathogens at the genetic level, offering greater accuracy and sensitivity compared to traditional diagnostic approaches. This enhanced precision is essential for the early identification of infectious diseases, which leads to improved animal health outcomes. Furthermore, molecular diagnostics are highly effective in detecting emerging or novel pathogens that may be difficult to identify using conventional methods. This is particularly important in managing evolving infectious disease risks, including zoonotic diseases that can impact both animals and humans. Advancements in molecular technologies, such as miniaturization and automation, have also made these diagnostic tools more affordable and accessible to veterinary clinics and research institutions, driving their widespread adoption.
Animal Type Insights
Based on Animal Type, the companion animals emerged as the dominating segment in the global market for Veterinary Infectious Disease Diagnostics in 2024. As pets are increasingly regarded as family members, there is a stronger focus on providing them with premium care. Pet owners are more inclined to invest in veterinary services, including diagnostic tests, to ensure their pets' health and well-being. This shift in mindset is driving the demand for advanced diagnostic technologies for companion animals. Additionally, the rising number of pet-owning households, particularly those with dogs and cats, is fueling the need for veterinary care. As the pet population grows, the demand for diagnostics to detect and manage infectious diseases also increases. Pet owners are becoming more proactive about their pets' health, seeking early diagnoses and preventive care to enhance their pets' longevity and quality of life. This growing awareness has led to a greater reliance on diagnostics for early detection of infectious diseases, such as viral, bacterial, and parasitic infections. Furthermore, the expanding market for pet pharmaceuticals, vaccinations, and healthcare products further supports the need for diagnostic testing, with veterinary clinics and hospitals increasingly depending on these tools to guide treatment and improve care.
Regional Insights
Based on Region, North America emerged as the dominant region in the Global Veterinary Infectious Disease Diagnostics Market in 2024. North America, particularly the United States, boasts one of the highest rates of pet ownership globally, with a substantial proportion of households owning dogs, cats, and other pets. As of 2024, 66% of U.S. households have a pet, equating to approximately 86.9 million families. This growing pet population drives the increased demand for veterinary services, including diagnostic testing. The rising trend of treating pets as family members in North America is leading to a greater emphasis on high-quality, advanced care, thus driving the need for sophisticated diagnostic tools to maintain pet health and well-being. According to the American Pet Products Association (APPA), U.S. pet-related expenditures reached 147 billion in 2023. North America also has well-established veterinary healthcare infrastructure with access to cutting-edge diagnostic technologies. Veterinary clinics and hospitals in the region are equipped with state-of-the-art tools for detecting infectious diseases in animals, reinforcing the region's dominance in the market. Furthermore, North American pet owners are more inclined to invest in veterinary services, including diagnostics, treatments, and preventive care, which has significantly contributed to the market's growth. The widespread availability of pet health information through veterinary organizations, pet health websites, and media outlets has heightened awareness of the importance of diagnostics for infectious diseases, leading to greater adoption of advanced diagnostic methods. These factors collectively create a favorable environment for the continued growth of the veterinary infectious disease diagnostics market, solidifying North America's leadership in the industry.
In this report, the Global Veterinary Infectious Disease Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Veterinary Infectious Disease Diagnostics Market.
Global Veterinary Infectious Disease Diagnostics market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: